In a separate study, resveratrol was found to notably disrupt glucose metabolism by inhibiting the activity of the enzyme 6-phosphofructo-1-kinase (PFK) in MCF-7 breast cancer cells. The gene discussed is PFKM; the disease is breast carcinoma.